Resonance Health Ltd (RHT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Resonance Health Ltd (RHT) has a cash flow conversion efficiency ratio of 0.016x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$173.36K ≈ $122.66K USD) by net assets (AU$10.94 Million ≈ $7.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Resonance Health Ltd - Cash Flow Conversion Efficiency Trend (1992–2025)
This chart illustrates how Resonance Health Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Resonance Health Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Resonance Health Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Resonance Health Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Navakij Insurance Public Company Limited
BK:NKI
|
0.051x |
|
StarFlex Co. Ltd
KQ:115570
|
-0.017x |
|
Farmmi Inc
NASDAQ:FAMI
|
0.306x |
|
123fahrschule SE
DU:123F
|
-0.004x |
|
E for L Aim Public Company Limited
BK:EFORL
|
0.037x |
|
QMINES LTD
F:81V
|
N/A |
|
Observe Medical Asa
OL:OBSRV
|
-8.348x |
|
LEXINGTO GOLD NEW DL-003
F:XX40
|
N/A |
Annual Cash Flow Conversion Efficiency for Resonance Health Ltd (1992–2025)
The table below shows the annual cash flow conversion efficiency of Resonance Health Ltd from 1992 to 2025. For the full company profile with market capitalisation and key ratios, see Resonance Health Ltd (RHT) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$9.39 Million ≈ $6.64 Million |
AU$1.25 Million ≈ $883.40K |
0.133x | +4.77% |
| 2024-06-30 | AU$10.93 Million ≈ $7.73 Million |
AU$1.39 Million ≈ $981.57K |
0.127x | +902.92% |
| 2023-06-30 | AU$9.94 Million ≈ $7.03 Million |
AU$-157.03K ≈ $-111.11K |
-0.016x | +88.39% |
| 2022-06-30 | AU$10.69 Million ≈ $7.56 Million |
AU$-1.46 Million ≈ $-1.03 Million |
-0.136x | -237.76% |
| 2021-06-30 | AU$11.83 Million ≈ $8.37 Million |
AU$1.17 Million ≈ $826.80K |
0.099x | -25.34% |
| 2020-06-30 | AU$9.91 Million ≈ $7.01 Million |
AU$1.31 Million ≈ $927.46K |
0.132x | -51.71% |
| 2019-06-30 | AU$5.89 Million ≈ $4.17 Million |
AU$1.62 Million ≈ $1.14 Million |
0.274x | +199.74% |
| 2018-06-30 | AU$4.13 Million ≈ $2.93 Million |
AU$377.97K ≈ $267.44K |
0.091x | +220.94% |
| 2017-06-30 | AU$3.73 Million ≈ $2.64 Million |
AU$-282.32K ≈ $-199.76K |
-0.076x | -600.37% |
| 2016-06-30 | AU$4.03 Million ≈ $2.85 Million |
AU$60.94K ≈ $43.12K |
0.015x | -66.24% |
| 2015-06-30 | AU$4.41 Million ≈ $3.12 Million |
AU$197.16K ≈ $139.51K |
0.045x | +591.68% |
| 2014-06-30 | AU$3.34 Million ≈ $2.36 Million |
AU$-30.39K ≈ $-21.50K |
-0.009x | -114.89% |
| 2013-06-30 | AU$2.24 Million ≈ $1.59 Million |
AU$137.03K ≈ $96.96K |
0.061x | +88.56% |
| 2012-06-30 | AU$2.57 Million ≈ $1.82 Million |
AU$83.21K ≈ $58.88K |
0.032x | +180.57% |
| 2011-06-30 | AU$2.90 Million ≈ $2.05 Million |
AU$-116.55K ≈ $-82.47K |
-0.040x | -261.82% |
| 2010-06-30 | AU$3.21 Million ≈ $2.27 Million |
AU$79.81K ≈ $56.47K |
0.025x | -84.64% |
| 2009-06-30 | AU$3.30 Million ≈ $2.34 Million |
AU$534.73K ≈ $378.36K |
0.162x | +282.09% |
| 2008-06-30 | AU$2.68 Million ≈ $1.89 Million |
AU$113.37K ≈ $80.22K |
0.042x | +112.11% |
| 2007-06-30 | AU$2.72 Million ≈ $1.93 Million |
AU$-952.10K ≈ $-673.67K |
-0.350x | +93.64% |
| 2006-06-30 | AU$510.36K ≈ $361.11K |
AU$-2.81 Million ≈ $-1.99 Million |
-5.500x | -3213.17% |
| 2005-06-30 | AU$14.11 Million ≈ $9.98 Million |
AU$-2.34 Million ≈ $-1.66 Million |
-0.166x | +65.36% |
| 2004-06-30 | AU$2.87 Million ≈ $2.03 Million |
AU$-1.37 Million ≈ $-972.74K |
-0.479x | +65.55% |
| 2003-06-30 | AU$690.97K ≈ $488.90K |
AU$-961.07K ≈ $-680.02K |
-1.391x | -1660.74% |
| 2002-06-30 | AU$-7.14 Million ≈ $-5.05 Million |
AU$-636.33K ≈ $-450.24K |
0.089x | +110.92% |
| 2000-06-30 | AU$9.61 Million ≈ $6.80 Million |
AU$-7.84 Million ≈ $-5.55 Million |
-0.816x | -15.13% |
| 1999-06-30 | AU$7.38 Million ≈ $5.22 Million |
AU$-5.23 Million ≈ $-3.70 Million |
-0.709x | -270.85% |
| 1998-06-30 | AU$20.58 Million ≈ $14.56 Million |
AU$-3.93 Million ≈ $-2.78 Million |
-0.191x | -40.17% |
| 1997-06-30 | AU$13.92 Million ≈ $9.85 Million |
AU$-1.90 Million ≈ $-1.34 Million |
-0.136x | -783.41% |
| 1996-06-30 | AU$11.86 Million ≈ $8.39 Million |
AU$-183.10K ≈ $-129.55K |
-0.015x | -1208.20% |
| 1995-06-30 | AU$5.03 Million ≈ $3.56 Million |
AU$7.00K ≈ $4.95K |
0.001x | +103.78% |
| 1993-06-30 | AU$5.10 Million ≈ $3.61 Million |
AU$-188.00K ≈ $-133.02K |
-0.037x | -22.07% |
| 1992-06-30 | AU$5.26 Million ≈ $3.72 Million |
AU$-159.00K ≈ $-112.50K |
-0.030x | -- |
About Resonance Health Ltd
Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron conce… Read more